Open for feedback
Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Bioequivalence of medicines
This consultation is aimed at pharmaceutical companies seeking to demonstrate bioequivalence of medicines to support applications to Medsafe for regulatory approval of new and changed products. Prescribers and healthcare professionals with an interest in medicine regulation, in particular generic medicine approval, may also wish to participate. Medsafe is seeking your feedback on changes to the Guideline on the Regulation of Therapeutic Products in New Zealand: Part 6: Bioequivalence...
Topical corticosteroids: Proposal for the package labelling to state their potency
Medsafe is seeking your feedback on a proposed advisory statement for topical corticosteroids to include information about the potency (strength) on the container/package label. In March 2025, the Medicines Adverse Reactions Committee (MARC) reviewed the risk of topical steroid withdrawal reactions . The MARC commented that inappropriate overuse of topical corticosteroids is common and noted the recent action taken by the United Kingdom’s medicines regulator, the Medicines...
Closed for feedback
Putting Patients First: Modernising health workforce regulation
The Government is inviting New Zealanders to share their views on health workforce regulation by 11.59 pm Wednesday 30 April. On 28 March 2025, the Ministry published a...
Consultation on safety measures for the use of puberty blockers in young people with gender-related health needs
The consultation on safety measures for the use of puberty blockers in young people with gender-related health needs closed on 20 January 2025. We will now consider submissions. Background ...
Unlocking the potential of active ageing - Long-term Insights Briefing publication consultation
The Ministry of Health – Manatū Hauora is seeking written feedback on the proposed topic of its Long-term Insights Briefing by Monday 2 December 2024. Our proposed Long-term Insights Briefing...
Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials
This consultation is aimed at pharmaceutical companies, health care professional organisations and individuals involved in conducting clinical trials in New Zealand. People who participate in...
Suicide Prevention Action Plan 2025 - 2029 Consultation
Suicide prevention efforts in New Zealand are guided by these two documents : Every Life Matters – He Tapu te Oranga o ia Tangata: Suicide Prevention Strategy 2019–2029 (He Tapu te...
Developing the Hauora Māori Strategy 2025
The Ministry, as chief steward of the health system, is responsible for the development and delivery of a new Hauora Māori Strategy under the Pae Ora (Healthy Futures) Act 2022. Manatū Hauora is...